Activating the lung's antioxidant defense by targeting Nrf2 inhibits the development of emphysema
Monday, December 22, 2008 - 17:42
in Health & Medicine
Using a molecule similar to one found in an experimental cancer drug, researchers at the Johns Hopkins Bloomberg School of Public Health demonstrated that activation of a key component of the lung's antioxidant defense system, Nrf2, can prevent emphysema in mice.